Organigram
Request Update
Total Investment:
CATEGORY Cannabinoids
FOUNDED 2013
HQ Canada
THE BASICS

Invested $10M into Hyasynth Biologicals to scale up commercial production of biosynthetic cannabinoids synthesized in yeast. Organigram and Hyasynth have entered into an agreement that allows Organigram to purchase a significant quantity of cannabinoids produced by Hyasynth.

GO DEEPER
CBT INSIGHTS
INVESTMENTS
×
It's free to read exclusive
CBT content To keep viewing profiles and access exclusive data, register for a free Cell Based Tech account.

>To login, please enter your email address

Just A Few More Details
keyboard_arrow_down
  • Find investment opportunity
  • Find investors
  • Market analysis/research
  • Other
keyboard_arrow_down
  • Investment/Finance
  • Business Development
  • Engineering/Scientist
  • IT
  • Marketing/Advertising
  • Sales
  • Other